Promising approaches for AMD include anti‐neovascular therapies (including anti‐VEGF medications, laser treatments, and surgical options), inhibition of the complement and other inflammatory pathways, reduction of oxidative stress, suppression of lipofuscin and optic cycling, as well as innovative methods for atrophic AMD like RPE cell transplantation and stem cell regenerative therapy.[12] Prophylactic therapy utilizing antioxidants such as vitamin C, vitamin E, and beta carotene, in addition to statins, is indicated for patients in the early stages of AMD. The gene discussed is VEGFA; the disease is age-related macular degeneration.